Evaluating the progressive cardiovascular health benefits of short term high intensity interval training by Holloway, Kathryn et al.
1 
 
Title Page 1 
 2 
Kathryn Holloway, Denise Roche and Peter Angell. 3 
 4 
Evaluating the progressive cardiovascular health benefits of short-term high intensity 5 
interval training. 6 
 7 
Liverpool Hope University, School of Health Sciences, Hope Park, Taggart Avenue, Liverpool, 8 
L16 9JD. 9 
 10 
Corresponding author: 11 
Kathryn Holloway 12 
hollowk@hope.ac.uk 13 
01512913227 14 
 15 
 16 
Acknowledgements 17 
We would like to thank Mark Bell and Sean Muirhead for their contribution to the exercise 18 
programme. 19 
 20 
 21 
 22 
 23 
 24 
 25 
 26 
 27 
 28 
2 
 
Abstract 1 
Purpose  High-intensity training is recognised as a time efficient way of improving aerobic 2 
fitness. However, there is a lack of consensus regarding the temporal nature of adaptation 3 
response and which peripheral and cardiac changes occur using the same exercise stimulus and 4 
protocol. Therefore, this study aimed to evaluate the progression of vascular and cardiac 5 
changes over a 6-week training period. 6 
Methods  Twelve healthy males (age 21±2 years; 42.5±8.3 ml.min-1.kg-1) participated in a high-7 
intensity training programme consisting of 1-minute sprints, interspersed with 2 minutes active 8 
recovery, 3 days/week for 6 weeks on a cycle ergometer. Cardiac, vascular, blood lipids and 9 
VO2max measurements were taken at 0, 3 and 6 weeks and compared against a participant-10 
matched control group (age 21±2 years; 37.7 ± 8.3 ml.min-1.kg-1). 11 
Results   There was a significant improvement in VO2max (42.5±8.3 ml.min-1.kg-1 to 47.4 ± 8.5 12 
ml.min-1.kg-1; p=0.009) in the training group and a significant decrease in systolic blood 13 
pressure (8%) from 0-6 weeks (p=0.025).  There was a small yet significant decrease in ejection 14 
fraction and increased end-systolic volume in both groups over time (p=0.01) with no 15 
significant interaction effect (p>0.05). A between-group difference in peak velocity of early 16 
diastolic mitral annular motion was also observed (p=0.01). No improvements were seen in 17 
blood lipid profiles, central arterial stiffness and cardiometabolic risk score. 18 
Conclusions  Six weeks of high-intensity training increases aerobic fitness and is enough to 19 
stimulate initial reductions in peripheral pressure, but not sufficient to elicit structural and 20 
functional cardiac changes, reduce arterial stiffness or lower CV risk. 21 
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Abbreviations 26 
A    Peak velocity of late transmitral flow 27 
A’    Peak velocity of diastolic mitral annular motion 28 
Alx    Augmentation index  29 
AP    Central augmented pressure  30 
a-VDO2   Arterial-venous difference 31 
BMI    Body mass index 32 
COmax    Maximal cardiac output 33 
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CRF    Cardiorespiratory fitness 1 
CVD    Cardiovascular disease 2 
DBP    Diastolic blood pressure 3 
DP    Central aortic diastolic pressure  4 
E    Peak velocity of early diastolic transmitral flow 5 
E’    Peak velocity of early diastolic mitral annular motion 6 
EF    Ejection fraction 7 
FBG    Fasting blood glucose 8 
HDL-C   High-density lipoprotein cholesterol 9 
HIIT    High intensity interval training 10 
HR    Heart rate  11 
IVSd    Interventricular septum thickness at end -diastole 12 
LDL-C   Low-density lipoprotein cholesterol  13 
LV    Left ventricle 14 
LVEDV   Left ventricular end-diastolic volume 15 
LVESV   Left ventricular end-systolic volume 16 
LVIDd     Left ventricular internal diameter end diastole 17 
LVIDs    Left ventricular internal diameter end systole 18 
LVPWd   Left ventricular posterior wall thickness at end –diastole 19 
MAP    Mean arterial pressure  20 
NO     Nitric oxide 21 
PP    Central aortic pulse pressure  22 
PWV    Pulse wave velocity 23 
S’    Peak velocity of systolic mitral annular motion 24 
SBP    Systolic blood pressure 25 
SIT    Sprint interval training 26 
SP    Central aortic systolic pressure  27 
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SV    Stroke volume 1 
SVmax    Maximal stroke volume 2 
TC     Total cholesterol  3 
TG    Triglycerides  4 
 5 
 6 
Introduction 7 
An emerging body of evidence is highlighting the positive impact that high intensity interval 8 
training (HIIT) has on an individual’s physical health.  HIIT can be defined as repeated short 9 
bouts of high intensity aerobic exercise (typically >90% VO2max; Kessler et al. 2012) 10 
interspersed by periods of lower intensity passive or active recovery (Astorino et al. 2012).  11 
Numerous training studies have demonstrated the effectiveness of endurance training on 12 
cardiorespiratory fitness (CRF; Kemi et al. 2005; Leon, 1997).  However, more current research 13 
has identified HIIT as a more time efficient method compared to endurance training (Gormley 14 
et al. 2008; Helgerud et al. 2007) with HIIT eliciting greater increases in CRF within a variety 15 
of population groups including healthy sedentary (Weston et al. 2014) and heart failure patients 16 
(Angadi et al. 2015).  HIIT has also shown increased adherence rates compared to continuous 17 
training in healthy (Heisz et al., 2016) and diseased groups (Jung et al., 2015), highlighting its 18 
potential for wider use amongst the general population.  With a large percentage of the 19 
population not meeting the current physical activity guidelines, and lack of time as the biggest 20 
barrier (Godin et al. 1994), understanding how HIIT can improve overall cardiovascular health 21 
is fundamental.  In addition, with 64% of participants dropping out of a long-term exercise 22 
programmes within the first 8 weeks (Heisz et al., 2016), it is important to understand the 23 
immediate benefits of short-term HIIT. 24 
Fifteen minutes of daily high intensity exercise can reduce all-cause mortality risk by 25%, 25 
which is equivalent to completing 60 minutes of daily moderate intensity physical activity 26 
(Wen et al. 2011).  It has therefore been suggested that there is an inverse dose-response 27 
relationship between mortality risk and the proportion of high intensity exercise performed, 28 
which would suggest a need to endorse high intensity exercise (Gebel et al. 2015).  More 29 
specifically, HIIT has been shown to improve a variety of direct and indirect cardiovascular 30 
indices, with as little as six sessions of HIIT improving VO2max by 10% (Esfandiari et al. 2014).  31 
Notwithstanding the improvements seen in CRF, the key indices contributing to this 32 
enhancement remain elusive and so have been associated with a number of different 33 
physiological adaptations.  MacPherson et al. (2011) ascertained that 6 weeks of sprint-interval 34 
training mediated no change in cardiac function, but the augmentation in CRF was increased 35 
due to peripheral adaptations.  This has primarily been associated with enhanced vascular 36 
structure and function, provoking a greater blood flow through the vessels, consequently 37 
increasing oxygen availability and promoting a greater shear stress-induced nitric oxide (NO) 38 
bioavailability (Wisloff et al. 2007).  In support of this, Thijssen et al. (2009) showed a parallel 39 
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relationship between an increase in blood flow and increase in shear stress with increasing 1 
exercise intensity.  Consequently, an increase in NO release has been associated with an 2 
improvement in CV risk profile with recurring intermittent increases in shear stress instigating 3 
vascular adaptations and remodelling of the artery (Wilson et al. 2015).  The augmented shear 4 
associated with high-intensity exercise would predict an increased likelihood of notable 5 
vascular adaptations to HIIT, although there is limited data on the response in healthy 6 
individuals with studies mainly having been undertaken in diseased populations (Thijssen et 7 
al. 2009).  In fact, Tjonna et al. (2011) showed that HIIT is sufficient in maintaining normal 8 
vascular function in healthy adults but very limited potential for further vascular improvements 9 
due to the healthy nature of the subjects.  Despite this, Tinken et al. (2008) showed that exercise 10 
training initiates improvement in vasodilator function in healthy young men in as little as 2 11 
weeks.  This therefore raises the question of the effectiveness of HIIT in the general population 12 
who are currently free from cardiovascular disease but are of a sedentary nature, since 13 
peripheral adaptations are associated with CRF and consequently CV risk. 14 
Conversely, increases in cardio-respiratory fitness have also been associated with cardiac 15 
adaptations that have predominantly occurred during the active recovery phase that occurs in-16 
between the high-intensity intervals.  Astorino et al. (2017) found that 6 weeks of HIIT 17 
significantly increased CRF through an increase in maximal stroke volume (SVmax) and 18 
maximal cardiac output (COmax), but found no increase in arterial-venous difference (a-VDO2).  19 
Cardiac output is enhanced through the increase of LV volume and a decrease in peripheral 20 
resistance (Tschakert et al. 2013) which enhances end-diastolic volume and stroke volume 21 
(SV). Buchheit et al. (2013) describes that working at an intensity close to maximal SV triggers 22 
these cardiac adaptations in HIIT.  However, it is important to note that HIIT may not induce 23 
structural changes quickly (<6 weeks) as increases in SV have also been attributed to an 24 
increase in plasma volume thus eliciting increases in blood volume and subsequently SV.  25 
Therefore, it is important to ascertain at which point cardiac structural changes appear with 26 
HIIT since the intermittent nature of exercise and recovery has the potential to improve CRF 27 
and thus reduce CVD risk. 28 
High intensity interval training protocols vary amongst research groups in regards to exercise 29 
intensity, work: rest ratios, duration and frequency of exercise.  It is therefore difficult to fully 30 
elucidate the extent of potential simultaneous peripheral and cardiac changes that are induced 31 
by HIIT.  Only one study to date has incorporated both cardiac and vascular measurements 32 
using HIIT in adult males (Heydari et al. 2013) but this study adopted a sprint interval training 33 
(SIT) based protocol (8 second sprint, 12 second recovery) rather than an HIIT protocol.  HIIT 34 
has been shown to produce a lower perceived exertion and a higher positive affect in 35 
comparison to SIT (Wood et al. 2015) and therefore could be deemed more appropriate for the 36 
general population.  In addition, HIIT has also been deemed as a safe exercise regime to 37 
undertake even with high risk groups (Weston et al. 2014), thus furthermore allowing the 38 
protocol to be used beyond the general population if required. 39 
Exercise intensity, as opposed to duration, has been deemed as the most important variable in 40 
determining CRF (Karlsen et al. 2017).  With a clear association between cardio-respiratory 41 
fitness and CVD risk (Karlsen et al. 2017), it is important to understand which physiological 42 
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indices are primarily adapting with HIIT and the time-course of responses.  Therefore, this 1 
study investigated the simultaneous changes in peripheral and cardiac indices from a 2 
temporal perspective using a HIIT based protocol to elucidate potential cardiovascular 3 
improvements.  As a consequence, we hypothesise that HIIT will significantly improve 4 
indices of vascular function, which in turn may elicit cardiac changes in the form of an 5 
improvement in systolic function. 6 
 7 
Methods 8 
Study design 9 
Subjects were individually assigned to one of two parallel groups, an exercise intervention and 10 
control group.  The study was an open-label study, with an allocation ratio of 1:1.  The study 11 
took place in the exercise physiology laboratories, Liverpool Hope University, Liverpool, UK 12 
from January 2016 to April 2016. 13 
 14 
Subjects  15 
Subjects were recruited through University advertisements, email bulletins and notice boards. 16 
Inclusion criteria included healthy males, non-smokers, free from cardiac or respiratory 17 
pathologies and not taking regular medication.  Twenty-one subjects were recruited, with 14 18 
subjects assigned to the intervention group to complete a 6-week high-intensity exercise 19 
programme (age 21±2 years, body mass 73.5±9.5 kg, BMI 24±3 kg/m2) and 7 subjects were 20 
assigned to a control group (age 21 ± 2 years, body mass 71.4±7.6 kg, BMI 23±3 kg/m2).  Two 21 
subjects from the intervention group withdrew from the study due to injury that was gained 22 
outside of the exercise programme. 23 
This study was approved by the Ethics Committee of Liverpool Hope University and all 24 
subjects gave their written informed consent. 25 
 26 
Experimental design 27 
All physiological measurements were taken at baseline, 3 weeks and 6 weeks. All subjects 28 
refrained from consuming caffeine (6 hours), food (12 hours), alcohol (12 hours) and strenuous 29 
exercise (24 hours) before measurements were conducted.  Subjects successively completed 18 30 
HIIT sessions, with an average 89% completion rate.  Subjects were removed from the study 31 
if their completion rate was below 80%.  Subjects were tested and trained at the same time of 32 
day to avoid diurnal variation. Post training tests at 3 and 6 weeks were taken within 48-120 33 
hours after the last HIIT session.  Subjects were asked to maintain the same dietary intake and 34 
physical activity level as undertaken prior to the study. 35 
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All data was collected over 2 days of testing in a standard laboratory environment (room 1 
temperature 22°C, relative humidity 10%).   2 
 3 
Anthropometrics 4 
Total body and segmental body fat analysis was conducted using bioelectric impedance (Tanita 5 
T5896, Tokyo).  Height was measured to the nearest 0.1cm using a stadiometer (SECA, 6 
Germany) and weight was measured to the nearest 0.1kg using scales (SECA, Germany).  Body 7 
mass index was then calculated using the formula body mass (kg) divided by height squared 8 
(m). 9 
 10 
VO2MAX  11 
Subjects performed the VO2max test on a cycle ergometer (Lode Excalibur Sport, Lode B.V 12 
Technology, Groningen, Netherlands).  Breath by Breath analysis was collected through a 13 
Respiratory Ergostik (Geratherm, Bremen, Germany), evaluating the expired O2 and carbon 14 
dioxide (CO2) using the Blue Cherry software (CV% = 3%).  Calibration of the Ergostik 15 
occurred prior to every test with O2, CO2 and nitrogen gas percentages accounting for 16%, 16 
4% and 80% respectively.  Subjects were fitted with a H2 Polar HR monitor (Polar Team 2 17 
Heart Rate Monitor System) and then sat resting for 2 minutes to gain baseline respiratory 18 
values.  Following this, a 5-minute warm up was instructed at a power output corresponding to 19 
that of the initial stage of the ramp test (50 watts).  Once the warm up was complete, the ramp 20 
test instantaneously began with intensity increasing 25 watts per minute.  Subjects cycled at an 21 
rpm between 60 and 70 for as long as possible until exhaustion.  The test was terminated when 22 
rpm fell below 60 for longer than 10 seconds, while HR within 10 beats of the age related max 23 
and RER ≥1.15 displayed if a true VO2max was achieved.  Following this, a 2-minute cool down 24 
was advised, at 50 watts.  The VO2 for each 30 second epoch was averaged.  The maximum 30 25 
second average value was reported. 26 
 27 
Assessment of vascular structure and function. 28 
For all vascular measurements, subjects remained in a supine position for 10 minutes before 29 
testing commenced in a temperature-controlled room. 30 
Pulse wave analysis 31 
Pulse wave analysis measurements were attained using a SphygmoCor System (AtCor 32 
Medical, Sydney, Australia).  An automated cuff was placed around the upper left arm and was 33 
inflated to measure brachial systolic and diastolic pressures and central pressures.  34 
Measurements were taken twice.  A third test was completed if the previous two measurements 35 
were >5mmHg different from each other.  Following this, the cuff was re-inflated to capture 36 
the brachial waveforms and used to determine pulse wave reflection characteristics.  Central 37 
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Aortic Diastolic Pressure (DP) was calculated by the lowest pressure value recorded in a pulse 1 
and Central Aortic Systolic Pressure (SP) was calculated as the maximum pressure during 2 
aortic injection. Central Aortic Pulse Pressure (PP) was then calculated as Central Aortic 3 
Systolic Pressure (SP) minus the Central Aortic Diastolic pressure (DP).  The Central 4 
Augmented Pressure (AP) was calculated as the difference between the two pressure peaks 5 
during systole and the Augmentation Index (Alx) is the ratio of AP to PP. Mean Arterial 6 
Pressure (MAP) and Heart rate (HR) were also measured.  7 
Pulse wave velocity 8 
Pulse wave velocity measurements were attained using a SphygmoCor System (AtCor 9 
Medical, Sydney, Australia).  Measurements were standardised according to recommendations 10 
by Van Bortel et al. (2012).  PWV was taken from the left carotid artery to the left femoral 11 
artery with subjects laying in a supine position.  The distance between the carotid site and the 12 
manubrium sterni and the carotid to femoral artery distance was determined to the nearest 13 
millimetre (mm).  PWV was measured by aligning the high-fidelity tonometer with the carotid 14 
artery pulse, holding in position until full assessment was completed.  A pressure cuff was 15 
positioned around the upper left thigh.  Time delays between proximal and distal waveforms 16 
were then used to calculate PWV (m/s) by the following equation: PWV = D/Δt in which D is 17 
the distance (m) and Δt is the time interval (s).  The SphygomoCor software will only accept 18 
values that are within a standard deviation of ≤10%, which has been shown to be highly 19 
reproducible (Wilkinson et al. 1998). 20 
Vascular structure 21 
Brachial artery imaging was conducted using a VividQ ultrasound scanner (GE Healthcare, 22 
UK).  Scans were performed on the right arm with the subject in a supine position.  The 23 
ultrasound probe (6-13MHz) was placed above the antecubital fossa in the longitudinal plane.  24 
Femoral artery measurements were taken on the right leg, in a supine position, at the midpoint 25 
of the inguinal ligament.  Three wall-to-wall measures were taken of each artery using the 26 
Vividq calliper option and an average was calculated to give a true diameter (cm) value. 27 
 28 
Assessment of cardiac structure and function. 29 
Global and segmental cardiac structure and function were assessed using ultrasound 30 
echocardiography (Vivid Q, GE Healthcare, Norway).  Images were taken of the left ventricle 31 
(LV) in multiple planes from parasternal and apical acoustic windows.  All measurements were 32 
performed by a single experienced echocardiographer with the participant in the left lateral 33 
decubitus position.  34 
Parasternal long axis views allowed the collection of M-mode images at the tips of the mitral 35 
valve leaflets perpendicular to septal and posterior walls taking care to ensure clear endocardial 36 
definition.  From M-mode traces septal (IVSd) and LV posterior wall thickness (LVPWd) in 37 
diastole as well as LV chamber dimensions at end-diastole and systole (LVIDd, LVIDs) were 38 
assessed following American Society of Echocardiography guidelines (Lang et al. 2015).   39 
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Apical 4-chamber views were digitised to assess LV end-diastolic (LVEDV) and end-systolic 1 
(LVESV) volumes, which allowed the estimation of stroke volume (SV) and ejection fraction 2 
(EF) using Simpsons’ bi-plane method.  From the 4-chamber view, colour Doppler and then 3 
pulsed wave Doppler were used to assess peak flow velocities across the mitral valve.  Using 4 
a 4 mm sample volume in the area of peak flow LV early (E) and late (A) diastolic in-flow 5 
velocities were recorded.  From the same view, tissue-Doppler measures of myocardial wall 6 
velocities were recorded.  Taking care to adjust filters and scale and with the septal wall parallel 7 
to the ultrasound beam, we interrogated the mitral annulus at the septal wall, recording peak 8 
systolic (S’) as well as early (E’) and atrial (A’) diastolic tissue velocities.  The ratio of early 9 
to late diastolic filling and tissue velocities were formulated.  10 
Two-dimensional image optimisation including maintaining frame rate between 40 and 90 fps 11 
was performed.  For all measurements, images were analysed off-line by a single experienced 12 
technician.  Data reflect the average of 3-5 continuous cardiac cycles.  13 
 14 
Blood analysis 15 
A fasting 35 µm finger-capillary blood sample was collected in sterile conditions for the 16 
subsequent determination a number of  metabolic markers  including: fasting blood glucose 17 
(FBG, mmol.L-1), Total Cholesterol (TC, mmol.L-1), low-density lipoprotein cholesterol (LDL-18 
C, mmol.L-1), high-density lipoprotein cholesterol (HDL-C, mmol.L-1), Triglycerides (TG, 19 
mmol.L-1) and TC:HDL-C ratio.  The free-flow whole blood was analysed using a LDX 20 
Cholestech analyser (Cholestech Corporation, USA). 21 
 22 
Calculation of clustered metabolic risk score 23 
Standardised z scores were calculated for percentage body fat, TC-HDL ratio, Glucose, 24 
Triglycerides and MAP (based on the clustered risk score by Lamb et al. 2016).  These were 25 
then summed to create a composite clustered risk score.  This composite score of 26 
cardiometabolic risk may compensate for day to day fluctuations in individual risk factors.  27 
 28 
High intensity training intervention 29 
A five minute warm up of unloaded cycling at 60rpm preceded five 1 minute cycling bouts at 30 
90% of the subject’s VO2max, interspersed with 2 minutes, resistance free active recovery at 60 31 
rpm.  This was repeated 3 times a week for 6 weeks, reaching 15 minutes of exercise per 32 
session, using a cycle ergometer (Monark, Ergomedic 874E, Vansbro, Sweden) throughout.  33 
All training sessions were supervised to ensure completion of training.  Subject’s training load 34 
was adjusted at 3 weeks to align with any changes in VO2max found at the 3-week assessment 35 
point. 36 
 37 
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Statistics 1 
All statistical analysis was performed using SPSS v. 23 (IBM Statistics, UK).  To determine 2 
differences at 0, 3 and 6 weeks, an Analysis of Covariance (ANCOVA) was performed with 3 
the pre-variable as the covariate and the group as the between-subjects factor.  Bonferroni 4 
pairwise comparisons were used to determine at which time points these differences occurred.  5 
Partial eta squared (ŋ2) values provide estimates of effect sizes for the main analyses where 6 
partial ŋ2 ≥ 0.01, 0.09 and 0.25 classified as small, medium and large effect sizes respectively 7 
(MRC, 2009).  8 
 9 
Results 10 
Aerobic capacity  11 
Pairwise comparisons revealed that there was an improvement in maximal oxygen 12 
consumption (VO2max) in the exercise group from 0-6 weeks of 10% (p=0.009; partial ŋ2= 13 
0.191).  The control group exhibited no change in VO2max across the 6 weeks (p=.686). 14 
Vascular structure and function  15 
There was a significant decrease in peripheral SBP (p=0.005; partial ŋ2= 0.232) in the training 16 
group from 0-6 weeks.  There was also a significant main effect for PP over time (p=0.041; 17 
partial ŋ2= 0.204).  There were no other significant group differences in vascular structure and 18 
function across the training programme. 19 
PWV and vascular structure measurements did not significantly change after the exercise 20 
intervention (table 1). 21 
Cardiac structure and function  22 
There was a small yet significant decrease in ejection fraction and increase in end-systolic 23 
volume in both groups over time (p=0.01; partial ŋ2= 0.295 and partial ŋ2= 0.429 respectively) 24 
with no significant group effect or interaction (p>0.05).  A between group difference in E was 25 
also observed (p=0.01; partial ŋ2= 0.361) however this was due to greater early diastolic filling 26 
velocities in the training group pre-intervention that persisted throughout the study.  All other 27 
cardiac measurements were unchanged by the training intervention and not significantly 28 
different from the control group. 29 
Blood analysis and CV risk factors  30 
There were no significant group differences or training effects on clustered risk score (table 1; 31 
F (2, 22) = 0.483, p=0.623).  Anthropometric measurements were also not changed with the 32 
training programme (p>0.05).  33 
 34 
 35 
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Discussion 1 
This study, to current knowledge, is the first to investigate the simultaneous temporal changes 2 
in peripheral and cardiac indices to elucidate the cardiovascular response to HIIT in a 6 week 3 
period.  The main finding of this study is that HIIT elicited improvements in aerobic capacity, 4 
which are likely to be attributed to improved oxygen delivery and/or mitochondrial adaptations 5 
since no improvements in cardiac function or vascular function were seen.  In addition, there 6 
were no beneficial reductions in CV risk factors or central arterial stiffness, but an improvement 7 
in peripheral blood pressure was evident. 8 
Enhancements in cardiorespiratory fitness are strongly associated with cardiovascular risk 9 
reduction (Wilson et al. 2015). Kaminsky et al. (2013) reported that a rise of one metabolic 10 
equivalent (3.5 ml O2·kg−1·min−1) in VO2max improved CVD survival by 10-25%.  The present 11 
study found that aerobic fitness was significantly increased by 11% (5ml O2·kg−1·min−1) with 12 
the 6 week training programme, suggesting a reduction in overall CV risk.  However, the 13 
clustered metabolic risk score was not significantly changed with training, suggesting that a 14 
longer training period or greater volume of training is required to improve cardiometabolic 15 
profiles.  This is supported by Nybo et al (2010) who did not find any changes in total 16 
cholesterol, HDL and LDL after 12 weeks of HIIT.  However, they did show a significant 17 
reduction in fasting glucose levels from 5.7±0.2mM to 5.2±0.1mM.  Our subjects already had 18 
baseline fasting glucose values of 5.2±0.4mM and this therefore could explain why no 19 
reductions were observed with the training program, suggesting the lowest threshold had 20 
already been reached.   21 
An increase in VO2max of 11% is particularly large in comparison to similar studies, with 22 
Helgerud et al. (2007) showing an increase of only 7.2%.  However, Gormley et al. (2008) have 23 
previously shown that 6 weeks of high intensity training improves VO2max with moderate- 24 
(10.0%), vigorous- (14.3%), and the near-maximal-intensity (20.6%) exercise.  They 25 
concluded that the highest intensity used for the significant portion of training was more 26 
important than the mean intensity across the exercise protocol.  Across our 15 minute protocol, 27 
33% of that time was spent at a high intensity work rate of 90% VO2max.  However, Helgerud 28 
et al. (2007) included 57% of high intensity work at 88% VO2max suggesting that the proportion 29 
of high intensity training used is not necessarily indicative of improvements in VO2max with 30 
high intensity training.  Bacon et al. (2013) has recently observed that longer high intensity 31 
intervals of 3-5 minutes can generate a marked increase in VO2max.  However, our study 32 
deliberately included 1-minute work periods since Bacon et al. (2013) also observed that it 33 
would be unrealistic for significant proportions of the population to participate in such an 34 
exercise program that causes individuals to reach their upper limit for VO2max.  Our current 35 
study did not have any withdrawals from the training group, but did eliminate two subjects for 36 
not meeting the threshold attendance.  Therefore, using this time-efficient (15 minutes total 37 
exercise time) design may be a useful tool in significantly improving aerobic fitness in young 38 
adults. 39 
An association between higher aerobic fitness and lower central arterial stiffness has been 40 
previously identified (Eugene et al. 1986; Feske et al. 1988; Tarnawski et al. 1994), indicating 41 
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the influence that aerobic capacity has on large artery stiffness.  There was no significant 1 
change in PWV with training, suggesting no change in aortic stiffness, and no significant 2 
change in augmentation index (Alx) over the 6-week training period.  Alx provides an indicator 3 
of systemic arterial stiffness by measuring the contribution that the wave reflection makes to 4 
the arterial pressure waveform.  More recently, a dose-response relationship has been found 5 
between exercise intensity, rather than volume of exercise, in improvement in Alx (Ashor et 6 
al. 2014).  However, 6 weeks of high intensity exercise training was not enough to elicit any 7 
improvement in Alx.  Padilla et al. (2008) and Tanaka et al. (2006) have both shown that high 8 
intensity exercise is associated with the highest post-exercise shear stress.  Therefore, 9 
augmented NO release would result in a greater reduction in peripheral vascular resistance and, 10 
consequently, Alx (Ashor et al. 2014).  Conversely, Goto et al. (2003) showed that high 11 
intensity exercise augmented oxidative stress, which may negate the positive effect that shear 12 
stress has on endothelial function.  In addition, high intensity exercise has been shown to 13 
stimulate increases in blood flow leading to a non-laminar shear stress and thus resulting in no 14 
enhancement in endothelial function (Harrison et al., 2006).  Alx can be influenced by a number 15 
of factors including age, gender, height, heart rate and some blood lipids (Wilkinson et al. 16 
2002).  All subjects were matched in age and gender, and similar in height (176±5cm).  17 
However, no significant change in Alx was still observed when matched to 75% heart rate 18 
(Alx@75%).  19 
In relation to this, there was a significant decrease in peripheral SBP of 7% following 6 weeks 20 
of training, suggesting an improvement in vascular resistance.  Nybo et al. (2010) showed the 21 
same decrease (-8mmHg) following 12 weeks of HIIT, however these same changes also 22 
appeared in the prolonged running and strength training groups.  Cornelissen et al. (2013) 23 
showed that a lower training intensity had a small effect (+0.073) on reducing SBP in 24 
comparison to moderate (-4.8) and high (-3.6) intensity exercise.  However, these effects were 25 
dependent on hypertensive status.  High intensity interval training may lower SBP due to an 26 
increase in endothelial NO availability resulting from an increase in blood velocity (Batacan et 27 
al., 2016).  However, with no changes in Alx or central pressures, it would suggest that there 28 
may be other mechanisms which are enhancing vascular function with HIIT beyond increasing 29 
shear stress.   30 
However, it is important to note that recent studies have shown that central pressure is more 31 
strongly related to future cardiovascular events than brachial pressures (Roman et al. 2007; 32 
Pini et al. 2008; Jankowski et al. 2008).  Although central pulse pressure (PP) showed a 33 
significant main effect over time, both groups exhibited a decrease in PP which suggests a non-34 
training effect.  Smulyan et al. 2003 stated that PP measurements using the SphymoCor system 35 
can be variable (SD=13.6mmHg).  This therefore may explain the significant decrease of 3 36 
mmHg and 2mmHg found in the training and control groups respectively.  In addition, central 37 
arterial pulse pressure has also been associated with carotid intima-media thickness 38 
(Boutouyrie et al. 1999) and therefore with no changes in brachial or femoral vascular diameter, 39 
it is suggestive that the HIIT programme had no effect on vascular structure.   40 
There were no significant changes to any cardiac structural measures in response to training 41 
after 3 or 6 weeks.  Previous findings have demonstrated an impact of HIT training on LV 42 
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morphology, however the present study found no change in cardiac structural measures most 1 
likely due to the relatively short-duration of the study (Wislof et al, 2007).  Whilst significant 2 
decreases in ejection fraction were observed in both groups, these changes were small and 3 
likely to be of little consequence as values were within the normal interstudy reliability range 4 
of 7% (Grothues et al. 2002).  There was a significant difference in ESV between groups at 5 
each time-point but this is likely due to pre-intervention differences.  With no meaningful 6 
change in systolic function, these differences could be due to subtle heart rate variations with 7 
changes within normal measurement variation. 8 
Previous research has found improvements in autonomic cardiovascular control following 12 9 
weeks of training (Hedari et al. 2013), whilst improvements in cardiac function have been seen 10 
in cardiac patients including those with heart failure and coronary artery disease (Guiraud et 11 
al. 2012) and additionally, a reduction in endocardial damage (Cassidy et al. 2017).  The lack 12 
of meaningful changes in cardiac function in the present study may be as a result of the good 13 
health status observed in both the training and control groups.  In contrast to patients with 14 
cardiac disease, the subjects in the present study may have already been toward the upper end 15 
of the cardiac adaptations possible without substantial increases in training load.  Contrastingly, 16 
the length of intervention may not have been sufficient to elicit significant structural and 17 
functional changes at the cardiac level as the majority of studies who have seen these 18 
improvements have been greater than 12 weeks (Wisloff et al. 2007).   19 
Our study is strengthened by the supervision of all training sessions and the continual 20 
verification of participants working at the correct intensities and completing the training 21 
protocol.  Participants were recreationally active and were therefore asked to continue their 22 
normal habitual exercise that was monitored by training logs during the 6 weeks.  Control 23 
participants were recruited by convenience rather than random assignment and were matched 24 
for age, physical activity levels and health status.  They did exhibit a lower mean VO2max (4.75 25 
ml.min-1.kg-1 mean difference) compared to the training group, but pairwise analysis showed 26 
no significant difference between the groups at baseline (p=.242).  Although the control group 27 
were asked to maintain normal habitual exercise, this was not monitored.  Whilst our 28 
participants were classed as active, none of them were attaining the 150 minutes per week (self-29 
reported) that is nationally recommended (NHS, 2017).  Therefore, even though it might be 30 
supposed that greater improvements may have been gained in more sedentary or diseased 31 
individuals, it is important to ascertain the degree of improvement that a healthy adult can 32 
obtain, since 33% of men are still not meeting the current recommended physical activity 33 
guidelines (British Heart Foundation, 2015).  Although Gold standard methods were mainly 34 
employed, the measurement of resting arterial diameter was used solely as a marker of vascular 35 
structure; additional methods which assess functional vascular responsiveness (e.g. FMD) 36 
should be included in future studies.  Furthermore, heart rate was not monitored during the 37 
exercise training which may have helped ensure participants were operating at the desired 38 
intensity. 39 
Overall, six weeks of high-intensity training is enough to stimulate an increase in VO2max and 40 
a reduction in peripheral systolic pressure, but did not elicit significant structural and functional 41 
changes at a cardiac level or improvements in central arterial stiffness and CV risk factors.  42 
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This study intentionally used a 15-minute protocol, since “lack of time” has been deemed the 1 
most cited reason for not exercising, and adopted a HIIT protocol, as opposed to a SIT protocol, 2 
as this has been deemed as more applicable to the general population (Ziemann, et al. 2011).  3 
However, these findings demonstrate that although 15 minutes of high-intensity exercise 3 4 
times per week can improve cardiorespiratory fitness, it is not sufficient to improve cardiac 5 
indices, central arterial stiffness and blood lipid profiles and subsequently chronic disease risk 6 
reduction within a 6 week period.  This could be a result of employing this particular time-7 
efficient volume of exercise or the intensity of the work periods.  Further investigation is 8 
required to elicit the time course at which improvement in these indices become apparent when 9 
adopting a time-efficient HIIT protocol.  10 
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Table 1: Cardiometabolic and vascular indices before, mid-point and after the 6-week intervention period for the training group and control. 
 Training group (n=12) Control group (n=9) 
 0 weeks 3 weeks 6 weeks 0 weeks 3 weeks 6 weeks 
VO2max (mL·kg-1·min-1) 42.5 ± 8.3 44.3 ± 7.3 47.4 ± 8.5 *  37.7 ± 8.3 40.5 ± 8.7 40.0 ± 8.4 
VO2max (L·min-1) 3.1 ± 0.6 3.2 ± 0.6 3.4 ± 0.6  2.7 ± 0.7 3.0 ± 0.6 2.8 ± 0.7 
Clustered risk score -0.07 ± 0.57 -0.04 ± 0.89 -0.02 ± 0.88 -0.01 ± 0.32 0.05 ± 0.30 -0.03 ± 0.24 
SBP (mmHg) 126 ± 8 120 ± 7 116 ± 8* 116 ± 7 125 ± 10 119 ± 8 
DBP (mmHg) 70 ± 5 66 ± 8 65 ± 10 64 ± 8 65 ± 11 65 ± 7 
DP (mmHg) 70 ± 6 67 ± 7 66 ± 9  64 ± 7 69 ± 8 68 ± 6 
MAP (mmHg) 85 ± 6 80 ± 7  78 ± 8 77 ± 8 83 ± 9 80 ± 4 
SP (mmHg) 109 ± 6 104 ± 6  102 ± 8 101 ± 8 106 ± 10 102 ± 6 
PP (mmHg) 39 ± 6 37 ± 4 36 ± 6* 36 ± 5 37 ± 6 34 ± 7* 
AP (mmHg) 4 ± 3 3 ± 4 4 ± 3 2 ± 3 1 ± 5 1 ± 5 
Alx (%) 9 ± 8 8 ± 10 13 ± 9  7 ± 9 1 ± 13 4 ± 11 
PWV (ms) 6 ± 1 5 ± 1 5 ± 1 5 ± 1 5 ± 1 5 ± 1 
Brachial diameter (cm) 0.41 ± 0.05 0.44 ± 0.06 0.43 ± 0.04 0.42 ± 0.03 0.44 ± 0.06 0.43 ± 0.03 
Femoral diameter (cm) 0.67 ± 0.06 0.70 ± 0.06 0.70 ± 0.05 0.65 ± 0.05 0.65 ± 0.05 0.63 ± 0.05 
Data presented as mean ± SD. * P<0.05, significantly different from baseline. VO2max, maximal oxygen consumption; SBP, systolic blood pressure; 
DBP, diastolic blood pressure; DP, central aortic diastolic pressure; MAP, mean arterial pressure; SP, central aortic systolic pressure; PP, central 
aortic pulse pressure; AP, central augmented pressure; Alx, augmentation index; PWV, pulse wave velocity. 
20 
 
Table 2: Cardiac indices before, mid-point and after the 6-week intervention period for the training group and control. 
 Training group (n=12) Control group (n=9) 
 0 weeks 3 weeks 6 weeks 0 weeks 3 weeks 6 weeks 
IVSd (mm) 9.4 ± 1.4 8.9 ± 1.4 9.3 ± 1.3 8.0 ± 0.8 8.0 ± 1.1 8.3 ± 0.8 
LVPWd (mm) 9.5 ± 0.9 9.3 ± 1.5 9.7 ± 1.3 9.5 ± 0.9 9.4 ± 1.1 9.9 ± 0.8 
LVEDV (ml) 122.2 ± 17.2 118.4 ± 16.9 126.7 ± 12.7 120.2 ± 16.4 131.9 ± 16.9 122.1 ± 22.9 
LVESV (ml) 47.8 ± 10.7 52.1 ± 11.1 51.5 ± 6.5* 48.6 ± 6.2 58.8 ± 8.6 55.8 ± 11.2* 
SV (ml) 74.6 ± 12.8 66.3 ± 7.3 75.1 ± 9.9 71.6 ± 12.4 73.0 ± 9.8 66.2 ± 12.2 
EF (%) 61.0 ± 6.5 56.3 ± 4.5 59.1 ± 4.0* 59.4 ± 3.8 55.4 ± 3.1 54.3 ± 2.1* 
E (cm·s) 0.81 ± 0.07 0.84 ± 0.10 0.80 ± 0.10† 0.72 ± 0.04 0.74 ± 0.08 0.70 ± 0.10 
A (cm·s) 0.46 ± 0.08 0.45 ± 0.08 0.4 ± 0.10 0.41 ± 0.06 0.40 ± 0.05 0.40 ± 0.10 
E:A  1.82 ± 0.39 1.95 ± 0.49 2.07 ± 0.41 1.84 ± 0.33 1.91 ± 0.14 1.77 ± 0.15 
E’ (cm·s) 0.14 ± 0.02 0.14 ± 0.02 0.14 ± 0.02 0.16 ± 0.03 0.15 ± 0.03  0.14 ± 0.02 
A’ (cm·s) 0.08 ± 0.02 0.08 ± 0.02 0.07 ± 0.01 0.09 ± 0.04 0.08 ± 0.03 0.07 ± 0.01 
S’ (cm·s) 0.09 ± 0.02 0.10 ± 0.02 0.09 ± 0.02 0.10 ± 0.03 0.13 ± 0.07 0.08 ± 0.01 
Data presented as mean ± SD. * P<0.05, significantly different from baseline. † P<0.05, significantly different between groups. IVSd, 
interventricular septum thickness at end -diastole; LVPWd, left ventricular posterior wall thickness at end -diastole; LVEDV, left ventricular end-
diastolic volume; LVESV, left ventricular end-systolic volume; SV, stroke volume; EF, ejection fraction; E, peak velocity of early diastolic 
transmitral flow; A, peak velocity of late transmitral flow; E:A, ratio of E to A; E’, peak velocity of early diastolic mitral annular motion; A’, peak 
velocity of diastolic mitral annular motion; S’, peak velocity of systolic mitral annular motion.  
